Global Chemotherapy-Induced Nausea and Vomiting (CINV) & Postoperative Nausea and Vomiting (PONV) Market: Industry Analysis & Outlook (2018-2022)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 66
Inquire Before Buying

Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.

Postoperative Nausea and Vomiting (PONV) is referred to as a situation in which an inpatient experiences nausea and/or vomiting within the first 24-48 hours after undergoing surgery with general anesthesia. The incidence of PONV is 30% in the all post-surgical patients and 80% in high-risk patients. PONV is caused due to various factors including anesthetic choices, patient and surgery-specific. Treatment of PONV is done through prophylaxis and rescue treatment.

The U.S. emerged as a major region for the CINV & PONV market due to rising healthcare concerns and expenditure of the U.S. populace and growing CINV & PONV patient population.

The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.

The report “Global Chemotherapy-Induced Nausea and Vomiting (CINV) & Postoperative Nausea and Vomiting (PONV) Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the U.S., Europe along with the global market. The report profiles the key players of the market including Merck & Co., Inc., Kirin Holding Company Limited (ProStrakan), Eisai Co., Ltd. and Helsinn Holding S.A.

Global Chemotherapy-Induced Nausea and Vomiting (CINV) & Postoperative Nausea and Vomiting (PONV) Market: Industry Analysis & Outlook (2018-2022)

Table of Contents

1. CINV & PONV Overview
1.1 CINV
1.2 PONV

2. Global CINV & PONV Market
2.1 Global CINV Market Forecast by Value
2.2 Global PONV Market Forecast by Value

3. Regional CINV & PONV Market
3.1 The U.S. CINV & PONV Market Forecast by Value
3.2 The U.S. CINV & PONV Drugs Revenue by Categories
3.3 The U.S. CINV & PONV Drugs Revenue
3.3.1 The U.S. Aloxi Drug Revenue
3.3.2 The U.S. Aloxi Drug Revenue Forecast
3.3.3 The U.S. Emend Drug Revenue Forecast
3.4 The U.S. CINV Drugs Revenue
3.4.1 The U.S. Sustol Drug Revenue Forecast
3.4.2 The U.S. Cinvanti Drug Revenue Forecast
3.4.3 The U.S. Varubi Oral Drug Revenue Forecast
3.4.4 The U.S. Varubi IV Drug Revenue Forecast
3.5 The U.S. PONV Patient Population Forecast
3.6 The U.S. PONV Drugs Revenue
3.6.1 The U.S. Baremsis Drug Revenue Forecast
3.7 Europe CINV Drugs Revenue
3.7.1 Europe Varuby Oral Drug Revenue Forecast
3.7.2 Europe Varuby IV Drug Revenue Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Cancer Incidence
4.1.2 Growing Female Population
4.1.3 Increasing Pharmaceutical R&D Spending
4.1.4 Growing Healthcare Expenditure
4.1.5 Accelerating Economic Growth
4.2 Key Trends and Developments
4.2.1 Progressing Drugs under Pipeline
4.2.2 High Demand for Combination Therapy
4.2.3 Increasing Preference for Pressure Point Therapy
4.3 Challenges
4.3.1 Entry of Generics
4.3.2 Stringent Regulations
4.3.3 Treatment Cost

5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 CINV & PONV Treatment Cost Comparison by Company
5.2 The U.S.
5.2.1 The U.S. CINV and PONV Market Share by Company

6. Company Profiles
6.1 Merck & Co., Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Eisai Co., Ltd.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Kirin Holding Company, Limited (ProStrakan)
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Helsinn Holding S.A.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Tables

Causes of PONV
Drugs under Development for CINV & PONV
Generics for CINV Therapies (2016-2018)
Key Players – Revenues Comparison (2017)
CINV & PONV Treatment Cost Comparison by Company (2018)
Helsinn Holding S.A. Drug Pipeline (2018)

List of Figures

Sub-Categories of CINV
Global CINV Market Forecast by Value (2017-2022)
Global PONV Market Forecast by Value (2017-2022)
The U.S. CINV & PONV Market Forecast by Value (2017-2022)
The U.S. CINV & PONV Drugs Revenue by Categories (2017)
The U.S. Aloxi Drug Revenue (2013-2017)
The U.S. Aloxi Drug Revenue Forecast (2018-2022)
The U.S. Emend Drug Revenue Forecast (2017-2022)
The U.S. Sustol Drug Revenue Forecast (2017-2022)
The U.S. Cinvanti Drug Revenue Forecast (2018-2022)
The U.S. Varubi Oral Drug Revenue Forecast (2018-2022)
The U.S. Varubi IV Drug Revenue Forecast (2018-2022)
The U.S. PONV Patient Population Forecast (2018-2022)
The U.S. Baremsis Drug Revenue Forecast (2019-2023)
Europe Varuby Oral Drug Revenue Forecast (2018-2022)
Europe Varuby IV Drug Revenue Forecast (2018-2022)
Global Cancer New Cases (2013-2017)
Global Female Population* (2013-2017)
Global Pharmaceutical R&D Spending (2013-2017)
Global Healthcare Expenditure (2013-2017)
Global GDP Per Capita (2013-2017)
The U.S. CINV and PONV Market Share by Company (2017)
Merck & Co., Inc. Net Sales by Business Segments (2017)
Merck & Co., Inc. Net Sales and Net Income (2013-2017)
Merck & Co., Inc. Research and Development Expenditures (2015-2017)
Eisai Co., Ltd. Revenues by Business Segments (2017*)
Eisai Co., Ltd. Revenues and Net Profit (2013-2017*)
Eisai Co., Ltd Research and Development Expenditures (2015-2017)
Kirin Holding (ProStrakan) Net Sales by Business Segments (2017)
Kirin Holding (ProStrakan) Net Sales and Net Income (Loss) (2013-2017)
Kirin Holding Company, Limited (ProStrakan) A&P Expenditures (2015-2017)
Helsinn Holding S.A. Net Sales (2013-2016)

  • Global Vegetable Capsules Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Vegetarian capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Vegetarian capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and HPMC (Hydroxyl Propyl Methyl Celluloses). Vegetarian capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; E......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Vegetable Capsules Market 2018, Forecast to 2023
    Published: 22-Jun-2018        Price: US 4880 Onwards        Pages: 131
    Vegetarian capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Vegetarian capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and HPMC (Hydroxyl Propyl Methyl Celluloses). Vegetarian capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; E......
  • Global Sugar Sphere Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Sugar spheres are a widely used excipient for sustained-release pellet formulations. Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical stability for further processing. Scope of the Report: This report focuses on the Sugar Sphere in global market, especially in North America, Europe and Asia-Pacific, South America,......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Sugar Sphere Market 2018, Forecast to 2023
    Published: 22-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Sugar spheres are a widely used excipient for sustained-release pellet formulations. Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical stability for further processing. Scope of the Report: This report focuses on the Sugar Sphere in global market, especially in North America, Europe and Asia-Pacific, South America,......
  • Global Androstenedione Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Jun-2018        Price: US 3480 Onwards        Pages: 152
    Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) - an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone. Scope of the Report: This report focuses on the Androstenedione in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Androstenedione is used to evaluate the function of t......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Androstenedione Market 2018, Forecast to 2023
    Published: 21-Jun-2018        Price: US 4880 Onwards        Pages: 148
    Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) - an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone. Scope of the Report: This report focuses on the Androstenedione in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Androstenedione is used to evaluate the function of t......
  • Global Soft Gelatin Capsules Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Jun-2018        Price: US 3480 Onwards        Pages: 152
    Soft Gelatin Capsules are a type of capsules with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Scope of the Report: This report focuses on the Soft Gelatin Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ap......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Soft Gelatin Capsules Market 2018, Forecast to 2023
    Published: 21-Jun-2018        Price: US 4880 Onwards        Pages: 150
    Soft Gelatin Capsules are a type of capsules with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Scope of the Report: This report focuses on the Soft Gelatin Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ap......
  • Global Keyhole Limpet Hemocyanin (KLH) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 129
    KLH, which can be used as an active pharmaceutical ingredient ("API"), is a very large, high molecular weight, oxygen-carrying glycoprotein made of millions of atoms. There are two KLH subunit forms, KLH1 and KLH2, each composed of seven or eight functional units, with each functional unit having an oxygen binding site of two copper atoms. Keyhole limpet hemocyanin is an extremely large, heterogeneous glycosylated protein consisting of subunits with a molecular weight of 350,000 and 390,000 in a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs